BLP 1654

Known as: BL P1654, (2S-(2 alpha,5 alpha,6 beta(S*)))-6-((((((aminoiminomethyl)amino)carbonyl)amino)phenylacetyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, BL-P1654 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
BL-P1654 is a new ureido-penicillin which has significant activity against both pseudomonas and klebsiella. Its pharmacokinetics… Expand
  • figure 1
  • table 1
  • figure 3
  • table 2
Is this relevant?
1977
1977
The activity of azlocillin, a new semisynthetic penicillin, was determined against 582 clinical isolates of gram-negative bacilli… Expand
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
1976
1976
The activity of ticarcillin, BL-P1654, and carbenicillin was compared in vitro using a microtiter tube dilution test in Mueller… Expand
Is this relevant?
1975
1975
The activity of BL-P1654, a semisynthetic penicillin, was studied in vitro against Enterobacteriaceae and compared with… Expand
Is this relevant?
1974
1974
BL-P1654 is a new ureido-penicillin which has significant activity against both pseudomonas and klebsiella. Its pharmacokinetics… Expand
Is this relevant?
1974
1974
Prior investigators have reported a broad gram-negative spectrum and a marked anti-Pseudomonas activity in vitro with BL-P1654, 6… Expand
  • table 2
  • table 3
  • table 1
  • figure 1
Is this relevant?
1974
1974
BL-P1654 is a new alpha-substituted ureido penicillin which has broad-spectrum activity. Doses of 0.5 and 1.0 g administered by… Expand
Is this relevant?
1971
1971
The susceptibilities of recently isolated strains of Pseudomonas aeruginosa to gentamicin, polymyxin B, carbenicillin, ampicillin… Expand
  • table 1
  • figure 1
  • table 2
Is this relevant?